Fingerprint
Dive into the research topics of 'Phase II Trial of Capecitabine and Weekly Docetaxel for Metastatic Castrate Resistant Prostate Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ulka N. Vaishampayan, Shanthi Marur, Lance K. Heilbrun, Michael L. Cher, Brenda Dickow, Daryn W. Smith, Samir A. Al Hasan, James Eliason
Research output: Contribution to journal › Article › peer-review